CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Scientific Officer acquired 80,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 240,000 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 80,000 shares (grant or award)
- 4 Grant or award SVP & Chief Medical Officer acquired 80,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 80,000 shares (grant or award)
- 4 Open-market sale President & CEO sold 16,466 shares at $10.53 ($173,443)
- 4 Open-market sale Director sold 3,847 shares at $11.16 ($42,919)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion SVP & Chief Medical Officer acquired 6,983 shares (option exercise)
- 4 Open-market sale President & CEO sold 16,466 shares at $12.06 ($198,499)
- 4 Open-market sale President & CEO sold 16,466 shares at an average $13.45 ($221,436)
- 4 Open-market sale Director sold 8,000 shares at an average $14.09 ($112,746)
- 4 Open-market sale Director sold 10,000 shares at an average $13.23 ($132,333)
- 4 Open-market sale President & CEO sold 16,466 shares at an average $14.22 ($234,222)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 15 · 288 filings